41  0 (0%)		08-07 16:00
Open: 44.17 High: 44.17 Volume: 174,004		Pre. Close: 41 Low: 41 Market Cap: 273(M)

Short term
Mid term
Targets	6-month :	57.23	1-year :	66.84
Resists	First :	49	Second :	57.23
Pivot price	22.62
Supports	First :	24.61	Second :	9.53
MAs	MA(5) :	40	MA(20) :	19.82
	MA(100) :	12.94	MA(250) :	11.7
MACD	MACD :	7.5	Signal :	4.3
%K %D	K(14,3) :	78.4	D(3) :	77.8
RSI	RSI(14): 96.1
52-week	High :	49	Low :	9.53

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ TENK ] has closed below upper band by 17.4%. Bollinger Bands are 1938.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	40.56 - 40.76	40.76 - 40.93
Low:	40.02 - 40.24	40.24 - 40.42
Close:	40.18 - 40.52	40.52 - 40.8

TenX Keane Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. The company was founded in 2021 and is based in New York, New York.

Fri, 09 Aug 2024
TenX Keane Acquisition Addresses Trading Halt, Continues - GlobeNewswire

Fri, 09 Aug 2024
TenX Keane addresses trading halt, continues toward combination closing - TipRanks

Tue, 06 Aug 2024
Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology - Nasdaq

Mon, 05 Aug 2024
TenX Keane Acquisition Shareholders Approve Previously - GlobeNewswire

Mon, 05 Aug 2024
Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc. - StockTitan

Tue, 18 Oct 2022
TenX Keane Acquisition Announces Closing of $66 Million - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	7 (M)
Shares Float	4 (M)
Held by Insiders	35.8 (%)
Held by Institutions	64.7 (%)
Shares Short	46 (K)
Shares Short P.Month	0 (K)

EPS	0.23
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.22
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	2 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	168.75
PEG Ratio	0
Price to Book value	-184.1
Price to Sales	0
Price to Cash Flow	-431.48

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.